Login

Jim Cramer sits down with RingCentral's CEO to discuss the company's role in the cloud and subscription economy. 00:10:00

Share On Facebook Share On Twitter

Vlad Shmunis is the Founder, Chairman, and CEO of RingCentral.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Building Trust: The Key to Successful Client Relationships
00:10:00
Ocean Ventures: Navigating Innovation, Investment, and Entrepreneurship | Lars Christian Skarsgård - Chief Executive Officer of Belships
00:10:00
Private Equity Firms Face Pressure for Distributions Amid Fundraising Challenges
00:10:00
The entrepreneur and the company-building process|Marc Andreessen,Investor, Andreessen Horowitz
00:10:00
A Conversation with Robert P. George: Constitutional Interpretation and Friendship Across Ideological Lines| Robert P. George,Professor,Princeton University
00:10:00
Panoro Minerals: Copper Exploration Success in Peru with Significant Resource Growth
00:10:00
FDA Grants Orphan Drug Designation to Cardiol Therapeutics' Lead Candidate for Recurrent Pericarditis| David Elsley, CEO, Cardiol Therapeutics Inc.
00:10:00
Market Outlook: Tech Valuations, M&A Trends, and Investment Strategies
00:10:00
Capital Markets Issuances: Insights from Daniel D. Camacho
00:10:00
Protecting Your Credit and Personal Data: Insights from Kim Curtis
00:10:00
How a Fee-Only Fiduciary Advisor Can Help You Reach Your Goals
00:10:00
Renren received a non-binding preliminary 'going private' offer from top executives at $4.20 per share in cash for each American depositary share.

© 2026 Nehu